Creative Planning
ALPN

Creative Planning’s Alpine Immune Sciences Inc ALPN Stock Holding History

Creative Planning’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-620
Closed -$6K – 3862
2017
Q2 		$6K Hold
620
– – ﹤0.01% 3932
2017
Q1 		$7K Sell
620
-50
-7% -$507 ﹤0.01% 3818
2016
Q4 		$6K Buy
670
+550
+458% +$11K ﹤0.01% 3882
2016
Q3 		$4K Hold
120
– – ﹤0.01% 4012
2016
Q2 		$2K Hold
120
– – ﹤0.01% 4069
2016
Q1 		$2K Hold
120
– – ﹤0.01% 4009
2015
Q4 		$4K Hold
120
– – ﹤0.01% 3817
2015
Q3 		$6K Buy
+120
New +$7.88K ﹤0.01% 3543

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning's ALPN Position: Q3 2017 in Review

Creative Planning sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2017, closing a stake of 620 shares — an estimated $6K sold.

Creative Planning first reported a position in ALPN in Q3 2015 and held it in 8 quarters. The position peaked at $7K in Q1 2017. 24 funds tracked by Wall St. Rank hold ALPN as of Q3 2017.

  • Creative Planning reported no remaining Alpine Immune Sciences Inc position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 620 Alpine Immune Sciences Inc shares in Q3 2017, an estimated $6K.
  • Creative Planning first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 8 quarters.
  • Creative Planning's Alpine Immune Sciences Inc position peaked at $7K in Q1 2017.
  • 24 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.